Intra-Cellular Therapies (ITCI) Announces CAPLYTA Schizophrenia Safety and Tolerability Profile Published in the Journal, International Clinical Psychopharmacology Jun 7, 2021 08:05AM
Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 15c, Revenues Miss May 10, 2021 07:35AM
Intra-Cellular Therapies (ITCI) Announces FDA Acceptance of CAPLYTA sNDAs for the Treatment of Bipolar Depression May 3, 2021 07:31AM
Intra-Cellular Therapies (ITCI) KOL Sees Good Chance of Caplyta Approval by Year End - Jefferies Apr 19, 2021 09:05AM
Intra-Cellular Therapies (ITCI) Tops Q4 EPS by 9c, Revenues Beat Feb 25, 2021 07:47AM
View Older Stories

Feb 22, 2021 08:09AM Intra-Cellular Therapies (ITCI) Applies for FDA Approval of CAPLYTA for the Treatment of Bipolar Depression
Jan 21, 2021 08:09AM Intra-Cellular Therapies (ITCI) Announces CAPLYTA Open-Label Safety Switching Study in Patients with Schizophrenia Published in the Journal, Schizophrenia Research
Dec 29, 2020 08:01AM Intra-Cellular Therapies (ITCI) Begins Clinical Trials for ITI-LLAI and for ITI-333
Dec 10, 2020 05:32AM UPDATE: Goldman Sachs Starts Intra-Cellular Therapies (ITCI) at Buy
Nov 9, 2020 07:36AM Intra-Cellular Therapies (ITCI) Tops Q3 EPS by 21c, Revenues Beat
Oct 1, 2020 04:33PM Intra-Cellular Therapies (ITCI) Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer
Sep 14, 2020 05:10PM Intra-Cellular Therapies (ITCI) Director Buys 50K Shares
Sep 11, 2020 05:52AM Intra-Cellular Therapies (ITCI) Prices 11.67M Share Common Offering at $30/Sh
Sep 9, 2020 04:54PM Intra-Cellular Therapies (ITCI) PT Raised to $80 at Canaccord Genuity
Sep 9, 2020 04:01PM Intra-Cellular Therapies (ITCI) to Offer $350M in Stock
Sep 9, 2020 01:59PM Intra-Cellular Therapies (ITCI) PT Raised to $80 at BTIG
Sep 9, 2020 12:33PM Intra-Cellular Therapies (ITCI) PT Raised to $54 at JMP Securities, Following Earnings
Sep 9, 2020 09:39AM Increasing unusual put option volume: ITCI FUN
Sep 9, 2020 07:16AM Intra-Cellular Therapies (ITCI) to Resume Trading at 7:30 a.m.
Sep 9, 2020 07:01AM Intra-Cellular Therapies (ITCI) Study 402 Evaluating Lumateperone as Adjunctive Therapy in Patients with Bipolar Depression Met the Primary Endpoint
Sep 9, 2020 06:57AM Intra-Cellular Therapies (ITCI) Halted, News Pending
Aug 10, 2020 07:33AM Intra-Cellular Therapies (ITCI) Misses Q2 EPS by 5c
Jun 29, 2020 08:01AM Intra-Cellular Therapies (ITCI) Reports Positive Top-line Results from ITI-214 Phase I/II Study in Patients with Heart Failure
May 7, 2020 07:58AM Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 20c, Revenues Miss
Mar 2, 2020 07:31AM Intra-Cellular Therapies (ITCI) Tops Q4 EPS by 7c
Feb 19, 2020 04:16PM Evercore ISI Starts Intra-Cellular Therapies (ITCI) at Outperform
Jan 8, 2020 05:54AM Intra-Cellular Therapies (ITCI) Prices 10M Share Common Offering at $29.50/Sh
Jan 6, 2020 05:55PM After-Hours Movers 01/06: (XERS) (CNXN) (MCHP) Higher; (ITCI) (ARE) (CRWD) Lower (more...)
Jan 6, 2020 04:07PM Intra-Cellular Therapies (ITCI) Announces Proposed 10M Share Common Offering
Jan 2, 2020 04:14AM Stocks with Implied Volatility Movement
Dec 27, 2019 04:35AM Stocks with Implied Volatility Movement
Dec 26, 2019 04:30AM Stocks with Implied Volatility Movement
Dec 24, 2019 09:16AM Pre-Open Stock Movers 12/24: (LCTX) (NLNK) (OTIC) (ITCI) (WCC)
Dec 24, 2019 08:16AM Intra-Cellular Therapies (ITCI) Adds to Yesterday's Gain, Up 12% Pre-Market
Dec 24, 2019 04:36AM Intra-Cellular Therapies (ITCI) option implied volatility at 141 after wide price movement
Dec 24, 2019 04:20AM Stocks with Implied Volatility Movement
Dec 23, 2019 11:29AM Intra-Cellular Therapies (ITCI) Halted on LUDP
Dec 23, 2019 11:29AM Intra-Cellular Therapies (ITCI) Extends Gain, Up 250%
Dec 23, 2019 10:31AM Intra-Cellular Therapies (ITCI) option implied volatility at 122 as shares rally 159%
Dec 23, 2019 10:22AM Increasing unusual option volume: SCVL CS HPE BTU LPSN DXCM LTM DRXX ITCI ALB NAT
Dec 23, 2019 10:17AM Intra-Cellular Therapies (ITCI) call put ratio 1.1 calls to 1 put after announces FDA approval of CAPLYTA
Dec 23, 2019 10:16AM Intra-Cellular Therapies (ITCI) IV at 120 after announces FDA approval of CAPLYTA
Dec 23, 2019 10:12AM Intra-Cellular Therapies (ITCI) Extends Gain, Up 164%
Dec 23, 2019 08:44AM Pre-Open Stock Movers 12/23: (ITCI) (CBB) (SDRL) (SLNO) (PGNX) (SRPT) (More..)
Dec 23, 2019 07:36AM Intra-Cellular Therapies (ITCI) extends gain after CAPLYTA approved by FDA for treatment of schizophrenia in adults, up 80%
Dec 23, 2019 07:00AM Intra-Cellular Therapies (ITCI) Receives FDA Approval of Novel Antipsychotic, CAPLYTA for Treatment of Schizophrenia in Adults
Dec 23, 2019 03:35AM Stocks with Implied Volatility Movement
Dec 17, 2019 04:38AM Stocks with Implied Volatility Movement
Dec 16, 2019 04:45AM Stocks with Implied Volatility Movement
Dec 13, 2019 04:41AM Stocks with Implied Volatility Movement
Dec 12, 2019 07:31AM Intra-Cellular Therapies (ITCI) Highlights Lumateperone Presentations at ACNP
Dec 11, 2019 03:09AM Stocks with Implied Volatility Movement
Dec 5, 2019 04:47AM Stocks with Implied Volatility Movement
Dec 4, 2019 04:45AM Stocks with Implied Volatility Movement
Dec 3, 2019 04:32AM Stocks with Implied Volatility Movement
View Older Stories